##gff-version 3
##sequence-region P22413 1 925
P22413	UniProtKB	Chain	1	925	.	.	.	ID=PRO_0000188564;Note=Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	
P22413	UniProtKB	Topological domain	1	76	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P22413	UniProtKB	Transmembrane	77	97	.	.	.	Note=Helical%3B Signal-anchor for type II membrane protein;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P22413	UniProtKB	Topological domain	98	925	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P22413	UniProtKB	Domain	104	144	.	.	.	Note=SMB 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00350	
P22413	UniProtKB	Domain	145	189	.	.	.	Note=SMB 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00350	
P22413	UniProtKB	Region	191	591	.	.	.	Note=Phosphodiesterase	
P22413	UniProtKB	Region	597	647	.	.	.	Note=Linker;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P22413	UniProtKB	Region	654	925	.	.	.	Note=Nuclease	
P22413	UniProtKB	Motif	45	52	.	.	.	Note=Di-leucine motif	
P22413	UniProtKB	Active site	256	256	.	.	.	Note=AMP-threonine intermediate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P06802	
P22413	UniProtKB	Metal binding	218	218	.	.	.	Note=Zinc 1%3B catalytic;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P06802	
P22413	UniProtKB	Metal binding	256	256	.	.	.	Note=Zinc 1%3B catalytic;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P06802	
P22413	UniProtKB	Metal binding	376	376	.	.	.	Note=Zinc 2%3B catalytic;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P06802	
P22413	UniProtKB	Metal binding	380	380	.	.	.	Note=Zinc 2%3B via tele nitrogen%3B catalytic;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P06802	
P22413	UniProtKB	Metal binding	423	423	.	.	.	Note=Zinc 1%3B catalytic;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P06802	
P22413	UniProtKB	Metal binding	424	424	.	.	.	Note=Zinc 1%3B via tele nitrogen%3B catalytic;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P06802	
P22413	UniProtKB	Metal binding	535	535	.	.	.	Note=Zinc 2%3B via tele nitrogen%3B catalytic;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P06802	
P22413	UniProtKB	Metal binding	800	800	.	.	.	Note=Calcium;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P06802	
P22413	UniProtKB	Metal binding	802	802	.	.	.	Note=Calcium;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P06802	
P22413	UniProtKB	Metal binding	804	804	.	.	.	Note=Calcium;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P06802	
P22413	UniProtKB	Metal binding	806	806	.	.	.	Note=Calcium%3B via carbonyl oxygen;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P06802	
P22413	UniProtKB	Metal binding	808	808	.	.	.	Note=Calcium;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P06802	
P22413	UniProtKB	Binding site	277	277	.	.	.	Note=Substrate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P06802	
P22413	UniProtKB	Binding site	295	295	.	.	.	Note=Substrate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P06802	
P22413	UniProtKB	Binding site	340	340	.	.	.	Note=Substrate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P06802	
P22413	UniProtKB	Site	102	103	.	.	.	Note=Cleavage;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P06802	
P22413	UniProtKB	Site	915	915	.	.	.	Note=Essential for catalytic activity;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P22413	UniProtKB	Modified residue	256	256	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q924C3	
P22413	UniProtKB	Glycosylation	179	179	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P22413	UniProtKB	Glycosylation	285	285	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P22413	UniProtKB	Glycosylation	341	341	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19159218,ECO:0000269|PubMed:19349973;Dbxref=PMID:19159218,PMID:19349973	
P22413	UniProtKB	Glycosylation	477	477	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P22413	UniProtKB	Glycosylation	585	585	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P22413	UniProtKB	Glycosylation	643	643	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19349973;Dbxref=PMID:19349973	
P22413	UniProtKB	Glycosylation	700	700	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P22413	UniProtKB	Glycosylation	731	731	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P22413	UniProtKB	Glycosylation	748	748	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19349973;Dbxref=PMID:19349973	
P22413	UniProtKB	Disulfide bond	108	122	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00350	
P22413	UniProtKB	Disulfide bond	112	140	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00350	
P22413	UniProtKB	Disulfide bond	120	133	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00350	
P22413	UniProtKB	Disulfide bond	126	132	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00350	
P22413	UniProtKB	Disulfide bond	149	166	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00350	
P22413	UniProtKB	Disulfide bond	154	184	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00350	
P22413	UniProtKB	Disulfide bond	164	177	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00350	
P22413	UniProtKB	Disulfide bond	170	176	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00350	
P22413	UniProtKB	Disulfide bond	195	241	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00350	
P22413	UniProtKB	Disulfide bond	203	415	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00350	
P22413	UniProtKB	Disulfide bond	431	530	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00350	
P22413	UniProtKB	Disulfide bond	480	868	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00350	
P22413	UniProtKB	Disulfide bond	614	672	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00350	
P22413	UniProtKB	Disulfide bond	626	726	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00350	
P22413	UniProtKB	Disulfide bond	628	711	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00350	
P22413	UniProtKB	Disulfide bond	838	848	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00350	
P22413	UniProtKB	Natural variant	91	91	.	.	.	ID=VAR_014141;Note=In OPLL. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10453738;Dbxref=PMID:10453738	
P22413	UniProtKB	Natural variant	92	92	.	.	.	ID=VAR_077255;Note=In ARHR2. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25741938;Dbxref=PMID:25741938	
P22413	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_077256;Note=In GACI1. C->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20016754;Dbxref=PMID:20016754	
P22413	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_077257;Note=In COLED. C->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26617416;Dbxref=PMID:26617416	
P22413	UniProtKB	Natural variant	149	149	.	.	.	ID=VAR_070782;Note=In COLED. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24075184;Dbxref=dbSNP:rs397518477,PMID:24075184	
P22413	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_070783;Note=In COLED. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24075184;Dbxref=dbSNP:rs397518476,PMID:24075184	
P22413	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_008873;Note=Polymorphism%3B associated with NIDDM%3B decreased nucleotide phosphodiesterase activity%3B no effect on localization to plasma membrane. K->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10453738,ECO:0000269|PubMed:10480624,ECO:0000269|PubMed:16186408,ECO:0000269|PubMed:20034067,ECO:0000269|PubMed:27467858;Dbxref=dbSNP:rs1044498,PMID:10453738,PMID:10480624,PMID:16186408,PMID:20034067,PMID:27467858	
P22413	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_077258;Note=In COLED. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26617416;Dbxref=PMID:26617416	
P22413	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_070784;Note=In COLED. C->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24075184;Dbxref=dbSNP:rs397518475,PMID:24075184	
P22413	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_037432;Note=N->S;Dbxref=dbSNP:rs2273411	
P22413	UniProtKB	Natural variant	195	195	.	.	.	ID=VAR_077259;Note=In GACI1%3B loss of nucleotide phosphodiesterase activity%3B loss of localization to plasma membrane. C->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27467858;Dbxref=dbSNP:rs763457176,PMID:27467858	
P22413	UniProtKB	Natural variant	195	195	.	.	.	ID=VAR_077260;Note=In GACI1%3B loss of nucleotide phosphodiesterase activity%3B loss of localization to plasma membrane. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27467858;Dbxref=PMID:27467858	
P22413	UniProtKB	Natural variant	216	216	.	.	.	ID=VAR_077261;Note=In GACI1%3B unknown pathological significance. S->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20016754;Dbxref=dbSNP:rs760786509,PMID:20016754	
P22413	UniProtKB	Natural variant	218	218	.	.	.	ID=VAR_077262;Note=In GACI1. D->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23430823;Dbxref=dbSNP:rs1231182870,PMID:23430823	
P22413	UniProtKB	Natural variant	219	219	.	.	.	ID=VAR_077263;Note=In ARHR2%3B unknown pathological significance. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25741938;Dbxref=PMID:25741938	
P22413	UniProtKB	Natural variant	242	242	.	.	.	ID=VAR_077264;Note=In GACI1%3B unknown pathological significance. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20016754;Dbxref=PMID:20016754	
P22413	UniProtKB	Natural variant	250	250	.	.	.	ID=VAR_067910;Note=In GACI1%3B unknown pathological significance. P->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15605415,ECO:0000269|PubMed:20016754;Dbxref=dbSNP:rs754659608,PMID:15605415,PMID:20016754	
P22413	UniProtKB	Natural variant	252	252	.	.	.	ID=VAR_067911;Note=In GACI1. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15605415;Dbxref=PMID:15605415	
P22413	UniProtKB	Natural variant	266	266	.	.	.	ID=VAR_063719;Note=In ARHR2. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20137773;Dbxref=dbSNP:rs121908248,PMID:20137773	
P22413	UniProtKB	Natural variant	268	268	.	.	.	ID=VAR_014142;Note=Y->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10453738;Dbxref=dbSNP:rs17847050,PMID:10453738	
P22413	UniProtKB	Natural variant	276	276	.	.	.	ID=VAR_077265;Note=In GACI1%3B unknown pathological significance. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20016754;Dbxref=dbSNP:rs143771474,PMID:20016754	
P22413	UniProtKB	Natural variant	287	287	.	.	.	ID=VAR_014143;Note=In OPLL. S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10453738;Dbxref=dbSNP:rs190947144,PMID:10453738	
P22413	UniProtKB	Natural variant	301	301	.	.	.	ID=VAR_077266;Note=In GACI1%3B loss of nucleotide phosphodiesterase activity%3B loss of localization to plasma membrane. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27467858;Dbxref=PMID:27467858	
P22413	UniProtKB	Natural variant	305	305	.	.	.	ID=VAR_067912;Note=In GACI1%3B loss of nucleotide phosphodiesterase activity%3B no effect on localization to plasma membrane. P->T;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15605415,ECO:0000269|PubMed:20016754,ECO:0000269|PubMed:27467858;Dbxref=dbSNP:rs374270497,PMID:15605415,PMID:20016754,PMID:27467858	
P22413	UniProtKB	Natural variant	342	342	.	.	.	ID=VAR_037433;Note=In GACI1. G->V;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15605415,ECO:0000269|PubMed:15940697,ECO:0000269|PubMed:20016754;Dbxref=dbSNP:rs121918025,PMID:15605415,PMID:15940697,PMID:20016754	
P22413	UniProtKB	Natural variant	349	349	.	.	.	ID=VAR_077267;Note=In GACI1%3B unknown pathological significance. R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20016754;Dbxref=dbSNP:rs764735802,PMID:20016754	
P22413	UniProtKB	Natural variant	371	371	.	.	.	ID=VAR_037434;Note=In GACI1%3B unknown pathological significance. Y->F;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15605415,ECO:0000269|PubMed:15940697,ECO:0000269|PubMed:20016754;Dbxref=dbSNP:rs121918026,PMID:15605415,PMID:15940697,PMID:20016754	
P22413	UniProtKB	Natural variant	456	456	.	.	.	ID=VAR_077268;Note=In GACI1. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20016754;Dbxref=dbSNP:rs765071179,PMID:20016754	
P22413	UniProtKB	Natural variant	471	471	.	.	.	ID=VAR_077269;Note=In GACI1%3B decreased nucleotide phosphodiesterase activity%3B no effect on localization to plasma membrane. Y->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20016754,ECO:0000269|PubMed:27467858;Dbxref=dbSNP:rs148462924,PMID:20016754,PMID:27467858	
P22413	UniProtKB	Natural variant	481	481	.	.	.	ID=VAR_077270;Note=In GACI1%3B unknown pathological significance. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20016754;Dbxref=dbSNP:rs373044722,PMID:20016754	
P22413	UniProtKB	Natural variant	500	500	.	.	.	ID=VAR_077271;Note=In GACI1. H->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20016754;Dbxref=PMID:20016754	
P22413	UniProtKB	Natural variant	504	504	.	.	.	ID=VAR_077272;Note=In GACI1%3B decreased nucleotide phosphodiesterase activity%3B no effect on localization to plasma membrane. S->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20016754,ECO:0000269|PubMed:27467858;Dbxref=PMID:20016754,PMID:27467858	
P22413	UniProtKB	Natural variant	513	513	.	.	.	ID=VAR_077273;Note=In GACI1%3B loss of nucleotide phosphodiesterase activity%3B no effect on localization to plasma membrane. Y->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20016754,ECO:0000269|PubMed:27467858;Dbxref=dbSNP:rs1243920034,PMID:20016754,PMID:27467858	
P22413	UniProtKB	Natural variant	538	538	.	.	.	ID=VAR_067913;Note=In GACI1%3B loss of nucleotide phosphodiesterase activity%3B no effect on localization to plasma membrane. D->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22209248,ECO:0000269|PubMed:27467858;Dbxref=dbSNP:rs387906673,PMID:22209248,PMID:27467858	
P22413	UniProtKB	Natural variant	570	570	.	.	.	ID=VAR_077274;Note=In GACI1. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20016754;Dbxref=dbSNP:rs140248167,PMID:20016754	
P22413	UniProtKB	Natural variant	579	579	.	.	.	ID=VAR_018514;Note=In GACI1%3B unknown pathological significance. L->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12881724,ECO:0000269|PubMed:20016754;Dbxref=dbSNP:rs121918024,PMID:12881724,PMID:20016754	
P22413	UniProtKB	Natural variant	586	586	.	.	.	ID=VAR_067914;Note=In GACI1%3B loss of nucleotide phosphodiesterase activity%3B loss of localization to plasma membrane. G->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22209248,ECO:0000269|PubMed:27467858;Dbxref=dbSNP:rs777367269,PMID:22209248,PMID:27467858	
P22413	UniProtKB	Natural variant	611	611	.	.	.	ID=VAR_077275;Note=L->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20016754;Dbxref=dbSNP:rs79079368,PMID:20016754	
P22413	UniProtKB	Natural variant	659	659	.	.	.	ID=VAR_077276;Note=In GACI1%3B decreased nucleotide phosphodiesterase activity%3B no effect on localization to plasma membrane. Y->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20016754,ECO:0000269|PubMed:27467858;Dbxref=dbSNP:rs143393727,PMID:20016754,PMID:27467858	
P22413	UniProtKB	Natural variant	668	668	.	.	.	ID=VAR_077277;Note=Polymorphism%3B no effect on nucleotide phosphodiesterase activity%3B no effect on localization to plasma membrane. E->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20016754,ECO:0000269|PubMed:27467858;Dbxref=dbSNP:rs115371819,PMID:20016754,PMID:27467858	
P22413	UniProtKB	Natural variant	726	726	.	.	.	ID=VAR_077278;Note=In GACI1. C->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20016754;Dbxref=PMID:20016754	
P22413	UniProtKB	Natural variant	774	774	.	.	.	ID=VAR_018515;Note=Polymorphism%3B decreased nucleotide phosphodiesterase activity%3B no effect on localization to plasma membrane. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12881724,ECO:0000269|PubMed:15605415,ECO:0000269|PubMed:20016754,ECO:0000269|PubMed:27467858;Dbxref=dbSNP:rs28933977,PMID:12881724,PMID:15605415,PMID:20016754,PMID:27467858	
P22413	UniProtKB	Natural variant	777	777	.	.	.	ID=VAR_077279;Note=In GACI1%3B decreased nucleotide phosphodiesterase activity%3B no effect on localization to plasma membrane. H->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20016754,ECO:0000269|PubMed:27467858;Dbxref=dbSNP:rs147346173,PMID:20016754,PMID:27467858	
P22413	UniProtKB	Natural variant	779	779	.	.	.	ID=VAR_014144;Note=T->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10453738;Dbxref=dbSNP:rs1805138,PMID:10453738	
P22413	UniProtKB	Natural variant	792	792	.	.	.	ID=VAR_077280;Note=In ARHR2 and GACI1. N->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20016754,ECO:0000269|PubMed:25741938;Dbxref=dbSNP:rs370184526,PMID:20016754,PMID:25741938	
P22413	UniProtKB	Natural variant	804	804	.	.	.	ID=VAR_077281;Note=In GACI1. D->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20016754;Dbxref=PMID:20016754	
P22413	UniProtKB	Natural variant	821	821	.	.	.	ID=VAR_077282;Note=Polymorphism%3B decreased nucleotide phosphodiesterase activity%3B no effect on localization to plasma membrane. R->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20016754,ECO:0000269|PubMed:27467858;Dbxref=dbSNP:rs367759638,PMID:20016754,PMID:27467858	
P22413	UniProtKB	Natural variant	886	886	.	.	.	ID=VAR_037435;Note=R->T;Dbxref=dbSNP:rs8192683	
P22413	UniProtKB	Natural variant	888	888	.	.	.	ID=VAR_077283;Note=In GACI1%3B loss of nucleotide phosphodiesterase activity%3B loss of localization to plasma membrane. R->W;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20016754,ECO:0000269|PubMed:27467858;Dbxref=dbSNP:rs184483616,PMID:20016754,PMID:27467858	
P22413	UniProtKB	Natural variant	901	901	.	.	.	ID=VAR_063720;Note=In ARHR2%3B loss of activity. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20137772;Dbxref=dbSNP:rs121908249,PMID:20137772	
P22413	UniProtKB	Turn	151	155	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2YS0	
P22413	UniProtKB	Beta strand	163	165	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2YS0	
P22413	UniProtKB	Helix	168	173	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2YS0	
P22413	UniProtKB	Helix	180	183	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2YS0	
